A Closer Look at Affinity Ligands

Feature
Article
Pharmaceutical TechnologyBio/Pharma Outsourcing Innovation, February 2024 eBook
Volume 2024 eBook
Issue 2
Pages: 16-21

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Graphene water filter, 3D illustration | Image Credit: © Dr_Microbe - stock.adobe.com; doctor analyzes monoclonal antibodies | Image Credit: © Paulista - stock.adobe.com; Final image by Maria Xelo

Graphene water filter, 3D illustration | Image Credit: © Dr_Microbe - stock.adobe.com; doctor analyzes monoclonal antibodies | Image Credit: © Paulista - stock.adobe.com; Final image by Maria Xelo

Affinity ligands play an exciting role in the ever-growing sphere of downstream processing. In speaking with Pharmaceutical Technology®, Phillip Elliott, PhD, associate director of Process Development, BioCina; Jan Bekker, PhD, director, Business Development, Commercial and Technical Operations, BioCina; and Parviz Shamlou, PhD, senior vice-president of Science & Technology, Abzena illuminate the newest innovations with affinity ligands and provide a deeper understanding of the role affinity ligands play in the future of downstream processing.

Read this article in Pharmaceutical Technology’s Bio/Pharma Outsourcing Innovation eBook.

About the author

Daria Husni is assistant editor to Pharmaceutical Technology® and Pharmaceutical Technology Europe®.

Article details

Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook
Issue 2
February 2024
Pages: 16-21

Citation

When referring to this article, please cite it as Husni, D. A Closer Look at Affinity Ligands. Pharmaceutical Technology, Bio/Pharma Outsourcing Innovation eBook. February 2024.

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Related Content